Related references
Note: Only part of the references are listed.The safety of statins in clinical practice
Jane Armitage
LANCET (2007)
Physician response to patient reports of adverse drug effects - Implications for patient-targeted adverse effect surveillance
Beatrice A. Golomb et al.
DRUG SAFETY (2007)
Statin-induced apoptosis and skeletal myopathy
Amie J. Dirks et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Lack of evidence for recommended low-density lipoprotein treatment targets: A solvable problem
Rodney A. Hayward et al.
ANNALS OF INTERNAL MEDICINE (2006)
Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives
N Krieger et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2005)
Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins
RJ Edison et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality
ML Daviglus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Drug treatment of hyperlipidemia in women
JME Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Prospective study of sudden cardiac death among women in the United States
CM Albert et al.
CIRCULATION (2003)
Statin use and the risk of breast cancer
P Beck et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Share Paper
